
Tumor Necrosis Factor Inhibitors and Lung Disease: A Paradox of Efficacy and Risk
Keywords: بیماری کرون; tumor necrosis factor inhibitors; pulmonary fibrosis; toxicity; granuloma; sarcoidosisADL, Adalimumab; BAL, Bronchoalveolar lavage; BSRBR, British Society of Rheumatology Biologics Registry; CD, Crohn's disease; COPD, Chronic obstructive pulmonary disease